Exposure to misoprostol and hormones during pregnancy and risk of congenital anomalies Exposição ao misoprostol e hormônios durante a gravidez e risco de anomalia congênita
This study evaluated the association between use of misoprostol and other drugs to induce menstruation, and congenital anomalies. A sample of 4,856 pregnant women 20 years and older were enrolled consecutively in prenatal services in the Unified National Health System, in six Brazilian State capital...
Saved in:
Main Authors: | Tatiane da Silva Dal Pizzol (Author), Maria Teresa Vieira Sanseverino (Author), Sotero Serrate Mengue (Author) |
---|---|
Format: | Book |
Published: |
Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz,
2008-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Misoprostol, aborto e malformações congênitas Misoprostol, abortion and congenital malformations
by: Sotero Serrate Mengue, et al.
Published: (2008) -
Endocrine disruptors and congenital anomalies Desreguladores endócrinos e anomalias congênitas
by: Mônica Rittler, et al.
Published: (2002) -
Misoprostol: a solução não é tão simples Misoprostol: the solution is not so easy
by: Helena Lutéscia L. Coêlho
Published: (1998) -
The effect of propranolol plus misoprostol with misoprostol alone on induction of labor
by: Atieh Mohammadzadeh Vatanchi, et al.
Published: (2021) -
Misoprostol Toxicity
by: Rubina Hussain, et al.
Published: (2024)